In breast cancer patients, particularly those with estrogen receptor-positive (ER+) tumors, soy isoflavones may imitate estrogen’s actions and promote the proliferation of breast cancer cells (Yamashita et al., 2022). The gene discussed is ESR1; the disease is breast carcinoma.